Global Pediatric Neuroblastoma Treatment Market Report 2024

Pediatric Neuroblastoma Treatment Global Market Report 2024 – By Treatment Type (Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types), By Risk Group (Low Risk, Intermediate Risk, High Risk), By End User (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Pediatric Neuroblastoma Treatment Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pediatric Neuroblastoma Treatment Market Definition And Segments

Pediatric neuroblastoma treatment refers to a kind of treatment for cancer or a tumor that affects the nervous system in children. Neuroblastoma is typically treated with a combination of surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy.

The main types of pediatric neuroblastoma treatments are immunotherapy, chemotherapy, radiation therapy, and others. Immunotherapy is a form of medical treatment that uses the immune system's power to fight disease. It is used to treat several risk groups, such as low risk, intermediate risk, and high risk, and is used by various end users including hospitals, specialty clinics, and others.

The pediatric neuroblastoma treatment market covered in this report is segmented –

1) By Treatment Type: Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types

2) By Risk Group: Low Risk, Intermediate Risk, High Risk

3) By End User: Hospitals, Specialty Clinics, Other End Users

The pediatric neuroblastoma treatment market size has grown rapidly in recent years. It will grow from $1.67 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to advancements in treatment modalities, increased awareness and early diagnosis, research and development initiatives, collaborative efforts, improved survival rates.

The pediatric neuroblastoma treatment market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging therapies, personalized medicine, global health initiatives, expanded access to treatment, patient advocacy and support. Major trends in the forecast period include collaborative research initiatives, gene therapy breakthroughs, novel drug development, early diagnosis and screening, patient advocacy and support.

Surging Pediatric Neuroblastoma Cases Propel Advancements In Treatment Market A Focus On Research, Innovation, And Early Detection

The rising number of new cases of pediatric neuroblastoma is expected to propel the growth of the pediatric neuroblastoma treatment market going forward. The rising prevalence of neuroblastoma is increasing the demand for pediatric neuroblastoma treatment alternatives. As a result, pharmaceutical corporations and other stakeholders have boosted their investment in research and development, promoting innovation in the industry. Furthermore, the availability of new diagnostic technology and screening procedures has resulted in earlier neuroblastoma discovery, allowing for earlier treatments and better outcomes. For instance, in March 2023, according to an article published by the American Society of Clinical Oncology (ASCO), a US-based organization for oncology professionals and physicians, neuroblastoma affects approximately 700 to 800 youngsters in the United States each year. In the United States, neuroblastoma accounts for 6% of all childhood malignancies. Neuroblastoma affects around 90% of children under the age of five. Therefore, the rising number of new cases of pediatric neuroblastoma is driving the growth of the pediatric neuroblastoma treatment market.

Rising Healthcare Infrastructure Investments Fueling Growth In The Pediatric Neuroblastoma Treatment Market

The increasing improvement in healthcare infrastructure is expected to propel the growth of the pediatric neuroblastoma treatment market. Healthcare infrastructure refers to the organizational and physical structures, buildings, processes, and resources that collectively enable the delivery of healthcare services within a community, region, or country. The healthcare infrastructure serves as the basis for pediatric neuroblastoma patients' diagnosis, treatment, and support. Its many components work together to provide comprehensive treatment, stimulate research and innovation, and improve the general health of children with neuroblastoma. For instance, in March 2022, the Department of Health and Aged Care, an Australia-based government agency in charge of funding, promoting, regulating, and doing health research, announced that the newly elected Coalition Government is investing a record $132 billion in 2022–23 for healthcare infrastructure, increasing to $140 billion in 2025–26, for a total commitment of $537 billion over the following four years. Therefore, the increasing improvement in healthcare infrastructure is driving the pediatric neuroblastoma treatment market.

Major companies operating in the pediatric neuroblastoma treatment market report are United Therapeutics Corporation, APEIRON Biologics AG, Baxter International Inc., Cell Ectar Biosciences Inc., Pfizer Inc., MacroGenics Inc., Bayer AG, Provectus Biopharmaceuticals Inc., Sartorius AG, Y-mAbs Therapeutics Inc., Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Clarity Pharmaceuticals, CureSearch for Children's Cancer, Novartis AG, LEO Pharma A/S, UCB SA, Johnson & Johnson Services Inc., Abbott Laboratories, AbbVie Inc., Merck & Co. Inc., Sanofi SA, GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd. .

Advancements In Pediatric Neuroblastoma Treatment Focus On Research And Development Initiatives By Leading Companies

Research and development are the key trend gaining popularity in the pediatric neuroblastoma treatment market. Major companies operating in the pediatric neuroblastoma treatment market are focusing on advance research and development to sustain their position in the market. For instance, in March 2021, Ascentage Pharma Group Inc., a US-based pharmaceutical company that develops novel cancer therapies, announced that the US Food and Drug Administration (FDA) had designated alrizomadlin (APG-115) as a rare pediatric disease (RPD) for the treatment of neuroblastoma. The FDASIA, which went into force in 2012, introduced the rare pediatric disease priority review voucher (PRV) program to reward sponsors for the discovery of innovative medicines for the treatment of rare pediatric disorders. Ascentage Pharma is developing alrizomadlin, an orally given, selective, small-molecule antagonist of the MDM2 protein. Alrizomadlin has a high affinity for MDM2 and is intended to stimulate p53's tumor suppressive activities by inhibiting the MDM2-p53 protein-protein connection.

Strategic Partnerships In Pediatric Neuroblastoma Treatment Market Drive Collaborative Breakthroughs

Major companies operating in the pediatric neuroblastoma treatment market are adopting a strategic partnership approach aiming to produce novel drug for high-risk neuroblastoma. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in August 2023, Renaissance Pharma Ltd., a UK-based biopharmaceutical company, announced a license agreement with the St. Jude Children’s Research Hospital for Hu14.18, a humanized antibody that the institution is developing for the medical management of newly identified high-risk neuroblastoma. Hu14.18 is a humanized anti-GD2 mAb. A unique Phase II study adding Hu14.18 to both induction and post-consolidation treatment exhibited excellent patient outcomes with an OS of 86.0% and EFS of 73.7%4. The licensing deal provides Renaissance Pharma with exclusive development, production, and commercialization rights in the United States, Canada, Europe, China, Japan, and Turkey. The St. Jude Children’s Research Hospital is a US-based research hospital.

Recordati S.P.A. Expands Pharmaceutical Portfolio With Acquisition Of Eusa Pharma (UK) Ltd., Enhancing Focus On Pediatric Neuroblastoma Treatment

In March 2022, Recordati S.p.A., an Italy-based pharmaceutical group, acquired EUSA Pharma (UK) Ltd. for $824.28 million. The acquisition is expected to offer Recordati a broader portfolio of pharmaceuticals for rare diseases. EUSA Pharma (UK) Ltd. is a UK-based specialty pharmaceutical company that deals in pediatric neuroblastoma treatment.

North America was the largest region in the pediatric neuroblastoma treatment market in 2023. The regions covered in the pediatric neuroblastoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric neuroblastoma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric neuroblastoma treatment market consists of revenues earned by entities by providing pediatric neuroblastoma treatment services such as stem cell therapy, supportive care and blood transfusions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric neuroblastoma treatment market also includes sales of pain management medications, chemotherapy drugs and immunotherapy agents which are used in providing pediatric neuroblastoma treatment services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pediatric neuroblastoma treatment market research report is one of a series of new reports from The Business Research Company that provides pediatric neuroblastoma treatment market statistics, including pediatric neuroblastoma treatment industry global market size, regional shares, competitors with a pediatric neuroblastoma treatment market share, detailed pediatric neuroblastoma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric neuroblastoma treatment industry. This pediatric neuroblastoma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pediatric Neuroblastoma Treatment Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.84 billion
Revenue Forecast In 2033 $2.58 billion
Growth Rate CAGR of 8.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment Type: Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types
2) By Risk Group: Low Risk, Intermediate Risk, High Risk
3) By End User: Hospitals, Specialty Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled United Therapeutics Corporation; APEIRON Biologics AG; Baxter International Inc.; Cell Ectar Biosciences Inc.; Pfizer Inc.; MacroGenics Inc.; Bayer AG; Provectus Biopharmaceuticals Inc.; Sartorius AG; Y-mAbs Therapeutics Inc.; Amgen Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; Clarity Pharmaceuticals; CureSearch for Children's Cancer; Novartis AG; LEO Pharma A/S; UCB SA; Johnson & Johnson Services Inc.; Abbott Laboratories; AbbVie Inc.; Merck & Co. Inc.; Sanofi SA; GlaxoSmithKline plc; Bristol-Myers Squibb Company; Takeda Pharmaceutical Company Limited; Astellas Pharma Inc.; Boehringer Ingelheim International GmbH; Daiichi Sankyo Company Limited; Eisai Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pediatric Neuroblastoma Treatment Market Characteristics

    3. Pediatric Neuroblastoma Treatment Market Trends And Strategies

    4. Pediatric Neuroblastoma Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Pediatric Neuroblastoma Treatment Market Size and Growth

    5.1. Global Pediatric Neuroblastoma Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Pediatric Neuroblastoma Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Pediatric Neuroblastoma Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Pediatric Neuroblastoma Treatment Market Segmentation

    6.1. Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Immunotherapy

    Chemotherapy

    Radiation Therapy

    Other Treatment Types

    6.2. Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Low Risk

    Intermediate Risk

    High Risk

    6.3. Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Other End Users

    7. Pediatric Neuroblastoma Treatment Market Regional And Country Analysis

    7.1. Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Pediatric Neuroblastoma Treatment Market  

    8.1. Asia-Pacific Pediatric Neuroblastoma Treatment Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Pediatric Neuroblastoma Treatment Market  

    9.1. China Pediatric Neuroblastoma Treatment Market Overview  

    9.2. China Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Pediatric Neuroblastoma Treatment Market  

    10.1. India Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Pediatric Neuroblastoma Treatment Market  

    11.1. Japan Pediatric Neuroblastoma Treatment Market Overview  

    11.2. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Pediatric Neuroblastoma Treatment Market  

    12.1. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Pediatric Neuroblastoma Treatment Market  

    13.1. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Pediatric Neuroblastoma Treatment Market  

    14.1. South Korea Pediatric Neuroblastoma Treatment Market Overview  

    14.2. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Pediatric Neuroblastoma Treatment Market  

    15.1. Western Europe Pediatric Neuroblastoma Treatment Market Overview

    15.2. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Pediatric Neuroblastoma Treatment Market  

    16.1. UK Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Pediatric Neuroblastoma Treatment Market  

    17.1. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Pediatric Neuroblastoma Treatment Market  

    18.5. France Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Pediatric Neuroblastoma Treatment Market  

    19.9. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Pediatric Neuroblastoma Treatment Market  

    20.13. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Pediatric Neuroblastoma Treatment Market  

    21.1. Eastern Europe Pediatric Neuroblastoma Treatment Market Overview

    21.2. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Pediatric Neuroblastoma Treatment Market  

    22.1. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Pediatric Neuroblastoma Treatment Market  

    23.1. North America Pediatric Neuroblastoma Treatment Market Overview

    23.2. North America Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Pediatric Neuroblastoma Treatment Market  

    24.1. USA Pediatric Neuroblastoma Treatment Market Overview

    24.2. USA Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Pediatric Neuroblastoma Treatment Market  

    25.1. Canada Pediatric Neuroblastoma Treatment Market Overview

    25.2. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Pediatric Neuroblastoma Treatment Market  

    26.1. South America Pediatric Neuroblastoma Treatment Market Overview

    26.2. South America Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Pediatric Neuroblastoma Treatment Market  

    27.1. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Pediatric Neuroblastoma Treatment Market  

    28.1. Middle East Pediatric Neuroblastoma Treatment Market Overview

    28.2. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Pediatric Neuroblastoma Treatment Market  

    29.1. Africa Pediatric Neuroblastoma Treatment Market Overview

    29.2. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Pediatric Neuroblastoma Treatment Market Competitive Landscape And Company Profiles

    30.1. Pediatric Neuroblastoma Treatment Market Competitive Landscape

    30.2. Pediatric Neuroblastoma Treatment Market Company Profiles

    30.2.1. United Therapeutics Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. APEIRON Biologics AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Baxter International Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Cell Ectar Biosciences Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Pfizer Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Pediatric Neuroblastoma Treatment Market Competitive Benchmarking

    32. Global Pediatric Neuroblastoma Treatment Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Pediatric Neuroblastoma Treatment Market

    34. Pediatric Neuroblastoma Treatment Market Future Outlook and Potential Analysis

    34.1 Pediatric Neuroblastoma Treatment Market In 2028 - Countries Offering Most New Opportunities

    34.2 Pediatric Neuroblastoma Treatment Market In 2028 - Segments Offering Most New Opportunities

    34.3 Pediatric Neuroblastoma Treatment Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: United Therapeutics Corporation Financial Performance
  • Table 75: APEIRON Biologics AG Financial Performance
  • Table 76: Baxter International Inc. Financial Performance
  • Table 77: Cell Ectar Biosciences Inc. Financial Performance
  • Table 78: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: United Therapeutics Corporation Financial Performance
  • Figure 75: APEIRON Biologics AG Financial Performance
  • Figure 76: Baxter International Inc. Financial Performance
  • Figure 77: Cell Ectar Biosciences Inc. Financial Performance
  • Figure 78: Pfizer Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the pediatric neuroblastoma treatment market?

Pediatric neuroblastoma treatment refers to a kind of treatment for cancer or a tumor that affects the nervous system in children. Neuroblastoma is typically treated with a combination of surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. For further insights on the pediatric neuroblastoma treatment market, request a sample here

How will the pediatric neuroblastoma treatment market drivers and restraints affect the pediatric neuroblastoma treatment market dynamics? What forces will shape the pediatric neuroblastoma treatment industry going forward?

The pediatric neuroblastoma treatment market major growth driver - surging pediatric neuroblastoma cases propel advancements in treatment market a focus on research, innovation, and early detection. For further insights on the pediatric neuroblastoma trea request a sample here

What is the forecast market size or the forecast market value of the pediatric neuroblastoma treatment market ?

The pediatric neuroblastoma treatment market size has grown rapidly in recent years. It will grow from $1.67 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to advancements in treatment modalities, increased awareness and early diagnosis, research and development initiatives, collaborative efforts, improved survival rates. The pediatric neuroblastoma treatment market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging therapies, personalized medicine, global health initiatives, expanded access to treatment, patient advocacy and support. Major trends in the forecast period include collaborative research initiatives, gene therapy breakthroughs, novel drug development, early diagnosis and screening, patient advocacy and support. For further insights on the pediatric neuroblastoma treatment market, request a sample here

How is the pediatric neuroblastoma treatment market segmented?

The pediatric neuroblastoma treatment market is segmented
1) By Treatment Type: Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types
2) By Risk Group: Low Risk, Intermediate Risk, High Risk
3) By End User: Hospitals, Specialty Clinics, Other End UsersFor further insights on the pediatric neuroblastoma treatment market,
request a sample here

Which region has the largest share of the pediatric neuroblastoma treatment market? What are the other regions covered in the report?

North America was the largest region in the pediatric neuroblastoma treatment market in 2023. The regions covered in the pediatric neuroblastoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the pediatric neuroblastoma treatment market, request a sample here.

Who are the major players in the pediatric neuroblastoma treatment market?

Major companies operating in the pediatric neuroblastoma treatment market report are United Therapeutics Corporation, APEIRON Biologics AG, Baxter International Inc., Cell Ectar Biosciences Inc., Pfizer Inc., MacroGenics Inc., Bayer AG, Provectus Biopharmaceuticals Inc., Sartorius AG, Y-mAbs Therapeutics Inc., Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Clarity Pharmaceuticals, CureSearch for Children's Cancer, Novartis AG, LEO Pharma A/S, UCB SA, Johnson & Johnson Services Inc., Abbott Laboratories, AbbVie Inc., Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd. . For further insights on the pediatric neuroblastoma treatment market, request a sample here.

What are the key trends in the pediatric neuroblastoma treatment market?

Major trend in the pediatric neuroblastoma treatment market - advancements in pediatric neuroblastoma treatment focus on research and development initiatives by leading companies. For further insights on the pediatric neuroblastoma treatment market, request a sample here.

What are the major opportunities in the pediatric neuroblastoma treatment market? What are the strategies for the pediatric neuroblastoma treatment market?

For detailed insights on the major opportunities and strategies in the pediatric neuroblastoma treatment market, request a sample here.

How does the pediatric neuroblastoma treatment market relate to the overall economy and other similar markets?

For detailed insights on pediatric neuroblastoma treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pediatric neuroblastoma treatment industry?

For detailed insights on the mergers and acquisitions in the pediatric neuroblastoma treatment industry, request a sample here.

What are the key dynamics influencing the pediatric neuroblastoma treatment market growth? SWOT analysis of the pediatric neuroblastoma treatment market.

For detailed insights on the key dynamics influencing the pediatric neuroblastoma treatment market growth and SWOT analysis of the pediatric neuroblastoma treatment industry, request a sample here.